ChemicalBook >> CAS DataBase List >>2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone
2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone
- CAS No.
- 133040-77-4
- Chemical Name:
- 2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone
- Synonyms
- LY 225910;LY 225910, CCK2 receptor antagonist;2-(2-(5-BroMo-1H-indol-3-yl)ethyl)-3-(3-isopropoxyphenyl)quinazolin-4(3H)-one;2-[2-(5-Bromo-1H-indol-3-yl)-ethyl]-3-(3-isopropoxy-phenyl)-3H-quinazolin-4-one;2-(2-(5-Bromo-(1H)-indol-3-yl)ethyl)-3-(3-(1-methylethoxy)phenyl)-4-(3H)-quinazoline;2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone;4(3H)-Quinazolinone, 2-[2-(5-bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-
- CBNumber:
- CB4349752
- Molecular Formula:
- C27H24BrN3O2
- Molecular Weight:
- 502.4
- MDL Number:
- MFCD00907856
- MOL File:
- 133040-77-4.mol
- MSDS File:
- SDS
- TDS File:
- TDS
Last updated:2026-09-12 18:52:45
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS06 |
|---|---|
| Signal word | Danger |
| Hazard statements | H301-H413 |
| Precautionary statements | P264-P270-P273-P301+P310-P405-P501 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | 3 |
2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone price More Price(32)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | L2545 | LY225910 ≥98% (HPLC) | 133040-77-4 | 25mg | $366 | 2026-04-30 | Buy |
| Sigma-Aldrich | L2545 | LY225910 ≥98% (HPLC) | 133040-77-4 | 5mg | $137 | 2022-05-15 | Buy |
| Usbiological | 453995 | LY 225910 | 133040-77-4 | 5mg | $403 | 2026-06-03 | Buy |
| Usbiological | 453995 | LY 225910 | 133040-77-4 | 10mg | $566 | 2026-06-03 | Buy |
| Biosynth | IFA04077 | LY 225910 | 133040-77-4 | 25mg | $775.75 | 2026-06-04 | Buy |
2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone Chemical Properties, Uses, Production
Uses
LY 225910 is a potent CCK-BR antagonist.
Definition
ChEBI: 2-[2-(5-bromo-1H-indol-3-yl)ethyl]-3-(3-propan-2-yloxyphenyl)-4-quinazolinone is a member of quinazolines.
Biological Activity
Potent CCK 2 receptor antagonist (IC 50 = 9.3 nM for inhibition of 125 I-labeled CCK-8 sulfate binding at mouse brain membranes).
storage
Desiccate at -20°C
2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone Preparation Products And Raw materials
Raw materials
Preparation Products
2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone Suppliers
Global Suppliers ( 41)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 3B Pharmachem (Wuhan) International Co.,Ltd. | 18930552037 | 3bsc@sina.com | China | 15813 | 69 |
| BOC Sciences | 1-631-485-4226; 16314854226 | info@bocsci.com | United States | 9920 | 65 |
| SynAsst Chemical. | 021-60343070 | China | 12731 | 55 | |
| EMMX Biotechnology LLC | 888-539-0666 | info@emmx.com | United States | 8435 | 60 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| MQ (shanghai) Pharmaceuticals Co., Ltd. | 13761635123 | sales@linyuepharm.com | China | 5731 | 55 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Energy Chemical | 400-0056266 | marketing1@energy-chemical.com | China | 44927 | 58 |
| TargetMol Chemicals Inc. | 4008200310 15002144251 | marketing@tsbiochem.com | China | 24951 | 58 |
| Shanghai Tachizaki Biomedical Research Center | 18014399201 | sales@chemlab-tachizaki.com | China | 2934 | 58 |
View Latest Price from 2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone manufacturers
133040-77-4 (2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone) Related Search:
LY 225910
2-(2-(5-Bromo-(1H)-indol-3-yl)ethyl)-3-(3-(1-methylethoxy)phenyl)-4-(3H)-quinazoline
2-(2-(5-BroMo-1H-indol-3-yl)ethyl)-3-(3-isopropoxyphenyl)quinazolin-4(3H)-one
2-[2-(5-Bromo-1H-indol-3-yl)-ethyl]-3-(3-isopropoxy-phenyl)-3H-quinazolin-4-one
4(3H)-Quinazolinone, 2-[2-(5-bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-
LY 225910, CCK2 receptor antagonist
2-[2-(5-Bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone
133040-77-4
C27H24BrN3O2






